Department of Medicine APP: GLP1s and Weight Loss Solutions - November 13, 2024
This is for leaners attending the live November 13, 2024, event to claim credit.
Target Audience
Pharmacists, Physician Assistants and Nurse Practitioners
Learning Objectives
At the end of this activity, the learner or the healthcare team should be able to:
- Summarize obesity as a disease state and the importance of safe and effective treatment, including management of adverse effects
- Identify approved treatment options and advocate for covered options based on various insurance coverage
- Critique information and misinformation around obesity treatment
BU CCE Program Manager: Naomi Moeller
In support of improving patient care, Boston University Chobanian & Avedisian School of Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physicians
Boston University Chobanian & Avedisian School of Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Available Credit
- 1.00 AMA PRA Category 1 Credit™
Boston University Chobanian & Avedisian School of Medicine designates this Enduring activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 1.00 Participation